Gap ledger
Fda status
1 record hold no fda status — no approved product, and no FDA evaluation of this fragment exists; the December 2024 compounding review on file examines AOD-9604, a different molecule.
Last updated
Gap ledger
1 record hold no fda status — no approved product, and no FDA evaluation of this fragment exists; the December 2024 compounding review on file examines AOD-9604, a different molecule.
Last updated